DIALYSIS DISPUTE : Adcock Ingram unit referred to Competition Tribunal over alleged excessive pricing of dialysis products
Adcock Ingram Critical Care has been referred to the Competition Tribunal for allegedly overpricing dialysis products essential for kidney treatment. The Competition Commission found that the company's prices significantly exceeded economic costs, indicating a potential abuse of market dominance. This case highlights concerns over the affordability of critical healthcare products in South Africa, particularly for patients with chronic kidney disease.
- ▪The Competition Commission referred Adcock Ingram Critical Care to the Competition Tribunal for alleged excessive pricing of dialysis products.
- ▪The complaint involves products used in peritoneal dialysis and continuous renal replacement therapy, crucial for kidney failure treatment.
- ▪The commission found that Adcock Ingram's prices during the investigation period were excessive and significantly exceeded economic costs.
Opening excerpt (first ~120 words) tap to expand
DIALYSIS DISPUTE Adcock Ingram unit referred to Competition Tribunal over alleged excessive pricing of dialysis products The Competition Commission has referred Adcock Ingram Critical Care to the Competition Tribunal for alleged excessive pricing of dialysis products used in the treatment of kidney failure, raising fresh questions about the cost of essential healthcare products in South Africa. By Neesa Moodley 4 Jun 2026 The Competition Commission has referred Adcock Ingram Critical Care to the Competition Tribunal for allegedly overpricing dialysis products crucial for kidney treatment.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Daily Maverick.